Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2004-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1196/annals.1306.012PMID 15105262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

  2008cited by this paper
• Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease

  2006cited by this paper
• Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia

  2004cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript*

  2002cited by this paper
• Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Alzheimer’s disease drug discovery targeted to the APP mRNA 5′Untranslated region

  2002cited by this paper
• The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease.

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

  2001cited by this paper
• Homocysteine potentiates copper‐ and amyloid beta peptide‐mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's‐type neurodegenerative pathways

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Treatment of Alzheimer’s Disease with Clioquinol

  2001cited by this paper
• Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc*

  2000cited by this paper
• Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

  2000cited by this paper
• Vitamin E Prevents Alzheimer's Amyloid ß-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production

  2000cited by this paper
• Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.

  2000cited by this paper
• Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.

  2000cited by this paper
• Association of interleukin‐1 gene polymorphisms with Alzheimer's disease

  2000cited by this paper
• Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.

  1999cited by this paper
• Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations.

  1999cited by this paper
• The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

  1999cited by this paper
• Amyloid β Peptides Do Not Form Peptide-derived Free Radicals Spontaneously, but Can Enhance Metal-catalyzed Oxidation of Hydroxylamines to Nitroxides*

  1999cited by this paper
• Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

  1999cited by this paper
• Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion*

  1999cited by this paper
• Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Alzheimer's disease

  1998cited by this paper
• Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation*

  1998cited by this paper
• Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis*

  1998cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• Alpha-2 macroglobulin is genetically associated with Alzheimer disease

  1998cited by this paper
• Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

  1997cited by this paper
• Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins*

  1997cited by this paper
• Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

  1997cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein.

  1997cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• α2‐Macroglobulin as a β‐Amyloid Peptide‐Binding Plasma Protein

  1997cited by this paper
• Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors*

  1997cited by this paper
• Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type--place of the extracellular glutathione peroxidase.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

  1996cited by this paper
• β-Amyloid toxicity in organotypic cultures : protection by EUK-8, a synthetic catalytic free radical scavenger

  1996cited by this paper
• The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)

  1996cited by this paper
• β-Amyloid-mediated vasoactivity and vascular endothelial damage

  1996cited by this paper
• beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger.

  1996cited by this paper
• Presence of soluble amyloid β–peptide precedes amyloid plaque formation in Down's syndrome

  1996cited by this paper
• Inhibition of Amyloid Protein Aggregation and Neurotoxicity by Rifampicin

  1996cited by this paper
• Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients

  1996cited by this paper
• Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

  1995cited by this paper
• A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains

  1995cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins.

  1995cited by this paper
• Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons.

  1995cited by this paper
• Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

  1995cited by this paper
• Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

  1995cited by this paper
• Candidate gene for the chromosome 1 familial Alzheimer's disease locus

  1995cited by this paper
• Multiple, diverse senile plaque–associated proteins are ligands of an apolipoprotein e receptor, the α2‐macroglobulin receptor/low‐density‐lipoprotein receptor—related protein

  1995cited by this paper
• Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.

  1995cited by this paper
• Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

  1995cited by this paper
• Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease.

  1994cited by this paper
• Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease.

  1994cited by this paper
• High expression on Kunitz-type protease inhibitor-containing substances in the cerebral vessels of patients with Down syndrome.

  1994cited by this paper
• Advanced Maillard reaction end products are associated with Alzheimer disease pathology

  1994cited by this paper
• Amyloid β protein levels in cerebrospinal fluid are elevated in early‐onset Alzheimer's disease

  1994cited by this paper
• Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

  1994cited by this paper
• Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

  1994cited by this paper
• Rapid induction of Alzheimer A beta amyloid formation by zinc.

  1994cited by this paper
• Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

  1994cited by this paper
• β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease

  1994cited by this paper
• Characterization of beta-amyloid peptide from human cerebrospinal fluid.

  1993cited by this paper
• Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid

  1993cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease.

  1993cited by this paper
• The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

  1993cited by this paper
• Immunohistochemical evidence of antioxidant stress in Alzheimer's disease

  1992cited by this paper
• Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

  1991cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper
• Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.

  1991cited by this paper
• A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

  1991cited by this paper
• Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

  1991cited by this paper
• In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

  1991cited by this paper
• In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity ☆

  1991cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• 11 The toxic effects of desferrioxamine

  1989cited by this paper
• The toxic effects of desferrioxamine.

  1989cited by this paper
• Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

  1988cited by this paper
• Brain tissue accumulates 67copper by two ligand-dependent saturable processes. A high affinity, low capacity and a low affinity, high capacity process.

  1988cited by this paper

• Potent anticancer activity of phenolic-enriched extracts from endemic plants supported by in vitro pharmacological analyses and in silico molecular docking

  2026cites this paper
• Neuroprotective Effects of Eugenol in Alzheimer's Disease: Mitigating Oxidative Stress, Inflammation and Amyloid Plaques.

  2025cites this paper
• Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

  2025cites this paper
• The interplay of oxidative stress and neurodegeneration: Nanoantioxidants as a novel therapeutic approach

  2025cites this paper
• A Cd(Ⅱ) coordination polymer: structure, fluorescent sensing of water pollutants, food additives, urinary biomarkers indicating exposure to these substances

  2025cites this paper
• Interplay of Metals and Organics in E-Cigarette Aerosols Enhances the Production of Reactive Oxygen Species within Ultrafine Particles: Implications for Passive Vaping Exposures.

  2025cites this paper
• Human Cyclophilins—An Emerging Class of Drug Targets

  2025cites this paper
• The role of metal element exposure and oxidative stress in mild cognitive impairment: Evidence from a Shanghai elderly cohort.

  2025cites this paper
• Integrating Microscopy Methods to Study Gene and Protein Expression alongside Metal Ion Distribution and Speciation: A Case Study of Iron within Pyramidal Neurons from Distinct Hippocampal CA1 Subregions

  2025cites this paper
• Oligomer sensitive in-situ detection and characterization of gold colloid aggregate formations observed within the hippocampus of the Alzheimer's disease rat.

  2025cites this paper
• On the origin of metal species in the human brain: a perspective on key physicochemical properties

  2025cites this paper
• The impacts of air pollution on mortality and hospital readmission among Medicare beneficiaries with Alzheimer’s disease and Alzheimer’s disease-related dementias: a national retrospective cohort study in the USA

  2025cites this paper
• Pathways to the Brain: Impact of Fine Particulate Matter Components on the Central Nervous System

  2025cites this paper
• Subventricular Accumulation of Cu in the Aging Mouse Brain Does Not Associate with Anticipated Increases in Markers of Oxidative Stress.

  2025cites this paper
• New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases

  2024cites this paper
• Diabetes Mellitus and Alzheimer's Disease: Understanding Disease Mechanisms, their Correlation, and Promising Dual Activity of Selected Herbs.

  2024cites this paper
• Implications of Liquid-Liquid Phase Separation and Ferroptosis in Alzheimer's Disease.

  2024cites this paper
• Innovative Approaches to Alzheimer's Therapy: Harnessing the Power of Heterocycles, Oxidative Stress Management, and Nanomaterial Drug Delivery System.

  2024cites this paper
• Iron imbalance in neurodegeneration

  2024cites this paper
• Chalcones As Modulators Of Neurodegenerative Processes: Exploring Their Role In Alzheimer's And Parkinson's Diseases

  2024cites this paper
• A reflexion on the oxidative stress and animal welfare: a review

  2024cites this paper
• Redox behaviour of Cu-Aβ(4-16) complexes related to Alzheimer's Disease

  2024cites this paper
• Protein Aggregation and its Affecting Mechanisms in Neurodegenerative Diseases.

  2024cites this paper
• Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer's disease.

  2023cites this paper
• Cerium oxide nanoparticles for surgery, plastic surgery and aesthetic medicine

  2023cites this paper
• Neuroprotective Effect of Propolis Polyphenol-Based Nanosheets in Cellular and Animal Models of Rotenone-Induced Parkinson's Disease.

  2023cites this paper
• Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer's Disease.

  2023cites this paper
• Orthosiphon aristatus (Blume) Miq. Extracts attenuate Alzheimer-like pathology through anti-inflammatory, anti-oxidative, and β-amyloid inhibitory activities.

  2023cites this paper
• Alzheimer's disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs.

  2023cites this paper
• Pentoxifylline as Add-On Treatment to Donepezil in Copper Sulphate-Induced Alzheimer’s Disease-Like Neurodegeneration in Rats

  2023cites this paper
• A Concise Review on Oxidative Stress-Mediated Ferroptosis and Cuproptosis in Alzheimer’s Disease

  2023cites this paper
• Antioxidant Compounds in the Treatment of Alzheimer's Disease: Natural, Hybrid, and Synthetic Products

  2023cites this paper
• Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer’s Disease

  2023cites this paper
• The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

  2023cites this paper
• The bs-YHEDA peptide protects the brains of senile mice and thus recovers intelligence by reducing iron and free radicals.

  2022cites this paper
• Recent Trend of Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's disease.

  2022cites this paper
• Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies

  2022cites this paper
• Dietary Polyphenols as Therapeutic Intervention for Alzheimer’s Disease: A Mechanistic Insight

  2022cites this paper
• Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities

  2022cites this paper
• New Insights into the Gut Microbiota in Neurodegenerative Diseases from the Perspective of Redox Homeostasis

  2022cites this paper
• Mechanistic Insight into the binding between Ferritin and Serotonin: Possible Implications in Neurodegenerative diseases

  2022cites this paper
• Synthesis and in vitro assessment of anticholinesterase and antioxidant properties of triazineamide derivatives.

  2022cites this paper
• ZOMEC via the p-Akt/Nrf2 Pathway Restored PTZ-Induced Oxidative Stress-Mediated Memory Dysfunction in Mouse Model

  2022cites this paper
• Microglia and Alzheimer’s Disease

  2022cites this paper
• A comprehensive and mechanistic review on protective effects of kaempferol against natural and chemical toxins: Role of NF‐κB inhibition and Nrf2 activation

  2022cites this paper
• New Multifunctional Agents for Potential Alzheimer’s Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones

  2022cites this paper
• Natural Carotenoids as Neuroprotective Agents for Alzheimer's Disease: An Evidence-Based Comprehensive Review.

  2022cites this paper
• The promising role of natural products in Alzheimer's disease

  2022cites this paper
• The accumulation of copper in the brain of Down syndrome promotes oxidative stress: possible mechanism underlying cognitive impairment

  2022cites this paper
• DDDT_A_288389 787..802

  2021cites this paper
• [Mapping the Metallo-maze to Memory Loss: Does Neuronal Metal Ion Deficiency Contribute to Dementia?]

  2021cites this paper
• A review of the "metallome" within neurons and glia, as revealed by elemental mapping of brain tissue.

  2021cites this paper
• The Effects of Redox-Active Metal Ions and Amyloid-Degrading Enzymes on the Pathology of Alzheimer's Disease

  2021cites this paper
• Synthesis, characterization, biological evaluation, and kinetic study of indole base sulfonamide derivatives as acetylcholinesterase inhibitors in search of potent anti-Alzheimer agent

  2021cites this paper
• A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases

  2021cites this paper
• Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease

  2021cites this paper
• Coordination of Redox Ions within a Membrane-Binding Peptide: A Tale of Aromatic Rings.

  2021cites this paper
• Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19

  2021cites this paper
• The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020

  2021cites this paper
• Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer’s Disease

  2021cites this paper
• Dopamine-Mediated Vanillin Multicomponent Derivative Synthesis via Grindstone Method: Application of Antioxidant, Anti-Tyrosinase, and Cytotoxic Activities

  2021cites this paper
• RalGPS2 Interacts with Akt and PDK1 Promoting Tunneling Nanotubes Formation in Bladder Cancer and Kidney Cells Microenvironment

  2021cites this paper
• Exercise and Antioxidants: Current Oxidative Stress Biomarkers: Future challenges and limitations

  2021cites this paper
• Casein micelles from bovine Milk exerts Neuroprotection by stalling metabolic complications linked to oxidative brain injury

  2020cites this paper
• On the propagation of the OH radical produced by Cu-amyloid beta peptide model complexes. Insight from molecular modelling.

  2020cites this paper
• Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling

  2020cites this paper
• Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer’s Disease

  2020cites this paper
• Tetrahydrocannabinol-Rich Extracts From Cannabis Sativa L. Improve Glucose Consumption and Modulate Metabolic Complications Linked to Neurodegenerative Diseases in Isolated Rat Brains

  2020cites this paper
• Catechol protects against iron‐mediated oxidative brain injury by restoring antioxidative metabolic pathways; and modulation of purinergic and cholinergic enzymes activities

  2020cites this paper
• In vitro and in vivo neuroprotective effects of Etifoxine in β-amyloidinduced toxicity models.

  2020cites this paper
• Can Brain Health Be Supported by Vitamin D-Based Supplements? A Critical Review

  2020cites this paper
• Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro

  2020cites this paper
• Cysteine in Alzheimer's Disease

  2020cites this paper
• Hippocampal T2 signal loss and decreased radial arm maze performance in transgenic murine model for AD

  2020cites this paper
• Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42)

  2020influential citation
• A Preliminary Study of Cu Exposure Effects upon Alzheimer’s Amyloid Pathology

  2020cites this paper
• Kolaviron Stimulates Glucose Uptake with Concomitant Modulation of Metabolic Activities Implicated in Neurodegeneration in Isolated Rat Brain, without Pertubation of Tissue Ultrastructural Morphology.

  2020cites this paper
• Characterization and Neuroprotection Potential of Seleno-Polymannuronate

  2020cites this paper
• Vital Role of MAO and ChE in CNS Drug Research: A Sharp Dissection of the Pathophysiology.

  2020cites this paper
• Amyloid β chaperone — lipocalin-type prostaglandin D synthase acts as a peroxidase in the presence of heme

  2020cites this paper
• Rutin ameliorates copper sulfate‐induced brain damage via antioxidative and anti‐inflammatory activities in rats

  2020cites this paper
• Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease

  2020cites this paper
• Amyloid β chaperone ‐ Lipocalin ‐ type Prostaglandin D synthase acts as a peroxidase in the presence of heme

  2020cites this paper
• Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration

  2020cites this paper
• Copper Modulation and Memory Impairment due to Hippocampal Tau Pathology

  2020cites this paper
• 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease.

  2020cites this paper
• Vanillin and vanillic acid modulate antioxidant defense system via amelioration of metabolic complications linked to Fe2+-induced brain tissues damage

  2020cites this paper
• Investigating in Vitro Amyloid Peptide 1–42 Aggregation: Impact of Higher Molecular Weight Stable Adducts

  2019cites this paper
• Ferulic Acid Modulates Dysfunctional Metabolic Pathways and Purinergic Activities, While Stalling Redox Imbalance and Cholinergic Activities in Oxidative Brain Injury

  2019cites this paper
• Multifunctional mono-triazole derivatives inhibit Aβ42 aggregation, Cu2+ mediated Aβ42 aggregation and protect against Aβ42 induced cytotoxicity.

  2019cites this paper
• Nitrite reductase activity of heme and copper bound Aβ peptides.

  2019cites this paper
• Beneficial Role of Curcumin in Preventing the Aggregation of the Amyloid-β Peptide in Alzheimer’s Disease

  2019cites this paper
• β‐Amyloid aggregation and heterogeneous nucleation

  2019cites this paper
• Genome aging: somatic mutation in the brain links age-related decline with disease and nominates pathogenic mechanisms.

  2019cites this paper
• Neuroprotective Function of Non-Proteolytic Amyloid-β Chaperones in Alzheimer’s Disease

  2019cites this paper
• Donepezil Derivatives Targeting Amyloid-β cascade in Alzheimer's Disease.

  2019cites this paper
• Mechanistic Insight into Tau Fibril Cross-Seeding Barriers: Structural Order and Disorder

  2019cites this paper
• Vernonia Amygdalina Del. stimulated glucose uptake in brain tissues enhances antioxidative activities; and modulates functional chemistry and dysregulated metabolic pathways

  2019cites this paper
• Neuromodulatory potential of phenylpropanoids; para-methoxycinnamic acid and ethyl-p-methoxycinnamate on aluminum-induced memory deficit in rats

  2019cites this paper
• Design and synthesis of thymine modified phthalocyanine for Aβ protofibrils photodegradation and Aβ peptide aggregation inhibition.

  2019cites this paper